Markers of non-alcoholic fatty liver disease (nafld) and...

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/92 (2006.01)

Patent

CA 2662987

Novel methods for assessing the level of triglycerides in the liver of a subject are described, comprising determining the amount of a lipid metabolite in a sample from a body fluid of the subject. The methods may be used, for example, in diagnosing and monitoring liver disorders such as steatosis, NAFLD and NASH.

La présente invention concerne de nouveaux procédés qui permettent d'évaluer le niveau de triglycérides dans le foie d'un sujet et consistent à déterminer la quantité d'un métabolite lipidique dans un échantillon de fluide corporel prélevé sur le sujet. Les procédés peuvent être utilisés, par exemple, pour le diagnostic et le suivi de troubles hépatiques tels que la stéatose, la NAFLD et la NASH.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Markers of non-alcoholic fatty liver disease (nafld) and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Markers of non-alcoholic fatty liver disease (nafld) and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Markers of non-alcoholic fatty liver disease (nafld) and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1769564

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.